IL129020A - Pharmaceutical preparations containing a history of S-alkylates and uranium - Google Patents

Pharmaceutical preparations containing a history of S-alkylates and uranium

Info

Publication number
IL129020A
IL129020A IL12902097A IL12902097A IL129020A IL 129020 A IL129020 A IL 129020A IL 12902097 A IL12902097 A IL 12902097A IL 12902097 A IL12902097 A IL 12902097A IL 129020 A IL129020 A IL 129020A
Authority
IL
Israel
Prior art keywords
use according
compound
medicament
formula
blood
Prior art date
Application number
IL12902097A
Other languages
English (en)
Hebrew (he)
Other versions
IL129020A0 (en
Original Assignee
Meditor Pharmaceutical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU96119163A external-priority patent/RU2142796C1/ru
Priority claimed from RU97115433/14A external-priority patent/RU2187309C2/ru
Application filed by Meditor Pharmaceutical Ltd filed Critical Meditor Pharmaceutical Ltd
Publication of IL129020A0 publication Critical patent/IL129020A0/xx
Publication of IL129020A publication Critical patent/IL129020A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/30—Isothioureas
    • C07C335/32—Isothioureas having sulfur atoms of isothiourea groups bound to acyclic carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biochemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL12902097A 1996-09-26 1997-09-25 Pharmaceutical preparations containing a history of S-alkylates and uranium IL129020A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
RU96119163A RU2142796C1 (ru) 1996-09-26 1996-09-26 Лекарственное противошоковое средство
RU97115433/14A RU2187309C2 (ru) 1997-09-19 1997-09-19 Средство, влияющее на артериальное давление
PCT/IL1997/000314 WO1998013036A1 (fr) 1996-09-26 1997-09-25 Compositions pharmaceutiques renfermant des derives de s-alkylisothiouronium

Publications (2)

Publication Number Publication Date
IL129020A0 IL129020A0 (en) 2000-02-17
IL129020A true IL129020A (en) 2004-06-20

Family

ID=26653892

Family Applications (1)

Application Number Title Priority Date Filing Date
IL12902097A IL129020A (en) 1996-09-26 1997-09-25 Pharmaceutical preparations containing a history of S-alkylates and uranium

Country Status (18)

Country Link
US (1) US6160008A (fr)
EP (1) EP0928191B1 (fr)
JP (1) JP4260888B2 (fr)
KR (1) KR100575507B1 (fr)
CN (1) CN1116871C (fr)
AT (1) ATE222758T1 (fr)
AU (1) AU717712B2 (fr)
BR (1) BR9712851A (fr)
CA (1) CA2266533C (fr)
DE (1) DE69715013T2 (fr)
DK (1) DK0928191T3 (fr)
ES (1) ES2182116T3 (fr)
HK (1) HK1022833A1 (fr)
IL (1) IL129020A (fr)
NO (1) NO326600B1 (fr)
PT (1) PT928191E (fr)
TR (1) TR199900783T2 (fr)
WO (1) WO1998013036A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100448439C (zh) * 2000-09-05 2009-01-07 麦迪特制药有限公司 用于头痛、偏头痛、恶心和呕吐的药物组合物
US20090018206A1 (en) * 2005-09-06 2009-01-15 Meditor Pharmaceuticals Ltd. Prevention of hypotension and stabilization of blood pressure in hemodialysis patients
US20090186854A1 (en) * 2006-03-23 2009-07-23 Meditor Pharmaceuticals Ltd. S-alkylisothiouronium derivatives for the treatment of inflammatory diseases
EA200901591A1 (ru) * 2007-06-13 2010-06-30 Медитор Фармасьютикалс Лтд. Фармацевтические композиции производных s-алкилизотиоурония с маскированным вкусом
US12011423B2 (en) 2007-11-06 2024-06-18 Foraviset Ltd. S-alkylisothiouronium derivatives for treating uterine hypercontractility disorders
EA030035B1 (ru) * 2007-11-06 2018-06-29 Меламед, Лемуил Применение s-этилизотиоурония диэтилфосфата для изготовления лекарственного средства для лечения нарушения матки
MD3619G2 (ro) * 2007-11-06 2009-01-31 Рафаэль Баркан Remediu medicamentos nazal cu acţiune anticongestivă
CN104140386A (zh) * 2014-02-12 2014-11-12 上海应用技术学院 一种2-苄基-异硫脲三氟乙酸盐的制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3123636A (en) * 1964-03-03 Thiuronium h alii
US3116327A (en) * 1960-07-22 1963-12-31 Baxter Laboratories Inc Upsilon-dimethylaminopropyl isothiourea and acid addition salts thereof
US3657337A (en) * 1967-12-04 1972-04-18 Sandoz Ag Benzylideneamino guanidines
FR2419675A1 (fr) * 1978-03-16 1979-10-12 Philagro Sa Compositions fongicides a base de phosphites d'isothiouronium
AT395012B (de) * 1986-06-27 1992-08-25 Richter Gedeon Vegyeszet Verfahren zur herstellung von n-(1(s)|thoxycarbonyl-3-phenyl-propyl)-(s)-alanyl-(s)prolin und von dessen saeureadditionssalzen

Also Published As

Publication number Publication date
PT928191E (pt) 2003-01-31
ES2182116T3 (es) 2003-03-01
EP0928191B1 (fr) 2002-08-28
CN1116871C (zh) 2003-08-06
US6160008A (en) 2000-12-12
NO991419D0 (no) 1999-03-24
AU717712B2 (en) 2000-03-30
DK0928191T3 (da) 2002-12-30
NO326600B1 (no) 2009-01-19
TR199900783T2 (xx) 1999-07-21
BR9712851A (pt) 2000-01-18
IL129020A0 (en) 2000-02-17
AU4317897A (en) 1998-04-17
DE69715013T2 (de) 2003-05-22
DE69715013D1 (de) 2002-10-02
CA2266533A1 (fr) 1998-04-02
WO1998013036A1 (fr) 1998-04-02
CA2266533C (fr) 2007-08-07
KR20000048636A (ko) 2000-07-25
EP0928191A1 (fr) 1999-07-14
NO991419L (no) 1999-05-21
ATE222758T1 (de) 2002-09-15
JP2001501928A (ja) 2001-02-13
HK1022833A1 (en) 2000-08-25
CN1234737A (zh) 1999-11-10
KR100575507B1 (ko) 2006-05-03
JP4260888B2 (ja) 2009-04-30

Similar Documents

Publication Publication Date Title
Clark et al. Long-lasting peripheral and central effects of 6-hydroxydopamine in rats
DE69533940T2 (de) Therapeutische zusammensetzungen von venösdilatoren und arterielldilatoren
US4167562A (en) Method and composition for treating arteriosclerosis
CA2152487C (fr) Procede de traitement d'un patient souffrant d'un traumatisme cardiaque
JPH0639383B2 (ja) 医薬組成物
JPS6221767B2 (fr)
EP0928191B1 (fr) Compositions pharmaceutiques renfermant des derives de s-alkylisothiouronium
Johnson Jr et al. Unique resistance to guanethidine-induced chemical sympathectomy of spontaneously hypertensive rats: a resistance overcome by treatment with antibody to nerve growth factor.
Davey et al. Pharmacology of the antihypertensive guanoxan
EP1057489B1 (fr) Utilisation de proteines de la famille des midkines pour le traitement des maladies ischemiques
DE69629282T2 (de) Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern
JPS6258336B2 (fr)
DE2743704C2 (de) L- oder DL-Phenylglycine enthaltende Arzneimittel
Mortell et al. Pheochromocytoma: case report with certain observations on the pathologic physiology
RU2338538C1 (ru) Антигипотензивное средство
US8106009B2 (en) Pharmaceutical composition for preventing or treating ischemic diseases
RU2295968C2 (ru) Комбинированный препарат, обладающий седативным, спазмолитическим и противоаллергическим действием
RU2122415C1 (ru) Способ интенсивной терапии у больных с травматическим шоком
US4571403A (en) Antianginal medicated compound
TWI672145B (zh) 預防及／或治療代謝疾病的醫藥組合物及其用途
Heard et al. A CLINICAL AND EXPERIMENTAL INVESTIGATION OF THE THERAPEUTIC VALUE OF CAMPHOR.
US4219566A (en) Phenylglyoxylic acids and derivatives thereof
US4239779A (en) Use of phenylglyoxylic acids and derivatives thereof in the treatment of ischemic heart disease
MEENU A Prospective Randomised Double-Blind Clinical Study to Compare Dexmedetomidine and Nitroglycerin for Controlled Hypotensive Anaesthesia in Spine Surgeries
JPWO2003068263A1 (ja) 高血圧症治療薬

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees